Next Generation Cancer Diagnostics Market Report

Global and Region Next Generation Cancer Diagnostics Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 29, 2022
  • PAGES：163
  • REPORT CODE：GMM892365
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Next Generation Cancer Diagnostics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Next Generation Cancer Diagnosticsmarket, defines the market attractiveness level of Next Generation Cancer Diagnostics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Next Generation Cancer Diagnostics industry, describes the types of Next Generation Cancer Diagnostics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Next Generation Cancer Diagnostics market and the development prospects and opportunities of Next Generation Cancer Diagnostics industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Next Generation Cancer Diagnostics market in Chapter 13.

    By Player:

    • Sysmex Corporation

    • Opko Health

    • Agilent Technologies

    • Abbott

    • Hologic

    • Genomic Health

    • Almac Group

    • Cepheid

    • Novartis AG

    • PerkinElmer

    • F Hoffmann-La Roche Ltd

    • GE Healthcare

    • Illumina

    • Qiagen

    • Koninklijke Philips NV

    • Thermo Fisher Scientific

    • Janssen Global Services

    • Myriad Genetics

    By Type:

    • Next Generation Sequencing

    • qPCR & Multiplexing

    • DNA Microarrays

    • Others

    By End-User:

    • Hospitals

    • Clinics

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Next Generation Cancer Diagnostics Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Next Generation Cancer Diagnostics Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Next Generation Cancer Diagnostics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Next Generation Cancer Diagnostics Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Next Generation Cancer Diagnostics Market Analysis and Outlook to 2022

    • 7.1 Global Next Generation Cancer Diagnostics Consumption (2017-2022)

    • 7.2 United States Next Generation Cancer Diagnostics Consumption (2017-2022)

    • 7.3 Europe Next Generation Cancer Diagnostics Consumption (2017-2022)

    • 7.4 China Next Generation Cancer Diagnostics Consumption (2017-2022)

    • 7.5 Japan Next Generation Cancer Diagnostics Consumption (2017-2022)

    • 7.6 India Next Generation Cancer Diagnostics Consumption (2017-2022)

    • 7.7 South Korea Next Generation Cancer Diagnostics Consumption (2017-2022)

    8 Region and Country-wise Next Generation Cancer Diagnostics Market Analysis and Outlook to 2028

    • 8.1 Global Next Generation Cancer Diagnostics Consumption Forecast (2022-2028)

    • 8.2 United States Next Generation Cancer Diagnostics Consumption Forecast (2022-2028)

    • 8.3 Europe Next Generation Cancer Diagnostics Consumption Forecast (2022-2028)

    • 8.4 China Next Generation Cancer Diagnostics Consumption Forecast (2022-2028)

    • 8.5 Japan Next Generation Cancer Diagnostics Consumption Forecast (2022-2028)

    • 8.6 India Next Generation Cancer Diagnostics Consumption Forecast (2022-2028)

    • 8.7 South Korea Next Generation Cancer Diagnostics Consumption Forecast (2022-2028)

    9 Global Next Generation Cancer Diagnostics Market Outlook by Types and Applications to 2022

    • 9.1 Global Next Generation Cancer Diagnostics Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Next Generation Sequencing Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global qPCR & Multiplexing Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global DNA Microarrays Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Next Generation Cancer Diagnostics Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Next Generation Cancer Diagnostics Market Outlook by Types and Applications to 2028

    • 10.1 Global Next Generation Cancer Diagnostics Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Next Generation Sequencing Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global qPCR & Multiplexing Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global DNA Microarrays Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Next Generation Cancer Diagnostics Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Next Generation Cancer Diagnostics Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Next Generation Cancer Diagnostics Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Next Generation Cancer Diagnostics Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Next Generation Cancer Diagnostics Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Next Generation Cancer Diagnostics Market Competitive Analysis

    • 14.1 Sysmex Corporation

      • 14.1.1 Sysmex Corporation Company Details

      • 14.1.2 Sysmex Corporation Next Generation Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Sysmex Corporation Next Generation Cancer Diagnostics Product and Service

    • 14.2 Opko Health

      • 14.2.1 Opko Health Company Details

      • 14.2.2 Opko Health Next Generation Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Opko Health Next Generation Cancer Diagnostics Product and Service

    • 14.3 Agilent Technologies

      • 14.3.1 Agilent Technologies Company Details

      • 14.3.2 Agilent Technologies Next Generation Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Agilent Technologies Next Generation Cancer Diagnostics Product and Service

    • 14.4 Abbott

      • 14.4.1 Abbott Company Details

      • 14.4.2 Abbott Next Generation Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Abbott Next Generation Cancer Diagnostics Product and Service

    • 14.5 Hologic

      • 14.5.1 Hologic Company Details

      • 14.5.2 Hologic Next Generation Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Hologic Next Generation Cancer Diagnostics Product and Service

    • 14.6 Genomic Health

      • 14.6.1 Genomic Health Company Details

      • 14.6.2 Genomic Health Next Generation Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Genomic Health Next Generation Cancer Diagnostics Product and Service

    • 14.7 Almac Group

      • 14.7.1 Almac Group Company Details

      • 14.7.2 Almac Group Next Generation Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Almac Group Next Generation Cancer Diagnostics Product and Service

    • 14.8 Cepheid

      • 14.8.1 Cepheid Company Details

      • 14.8.2 Cepheid Next Generation Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Cepheid Next Generation Cancer Diagnostics Product and Service

    • 14.9 Novartis AG

      • 14.9.1 Novartis AG Company Details

      • 14.9.2 Novartis AG Next Generation Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Novartis AG Next Generation Cancer Diagnostics Product and Service

    • 14.10 PerkinElmer

      • 14.10.1 PerkinElmer Company Details

      • 14.10.2 PerkinElmer Next Generation Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 PerkinElmer Next Generation Cancer Diagnostics Product and Service

    • 14.11 F Hoffmann-La Roche Ltd

      • 14.11.1 F Hoffmann-La Roche Ltd Company Details

      • 14.11.2 F Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 F Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Product and Service

    • 14.12 GE Healthcare

      • 14.12.1 GE Healthcare Company Details

      • 14.12.2 GE Healthcare Next Generation Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 GE Healthcare Next Generation Cancer Diagnostics Product and Service

    • 14.13 Illumina

      • 14.13.1 Illumina Company Details

      • 14.13.2 Illumina Next Generation Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Illumina Next Generation Cancer Diagnostics Product and Service

    • 14.14 Qiagen

      • 14.14.1 Qiagen Company Details

      • 14.14.2 Qiagen Next Generation Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Qiagen Next Generation Cancer Diagnostics Product and Service

    • 14.15 Koninklijke Philips NV

      • 14.15.1 Koninklijke Philips NV Company Details

      • 14.15.2 Koninklijke Philips NV Next Generation Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Koninklijke Philips NV Next Generation Cancer Diagnostics Product and Service

    • 14.16 Thermo Fisher Scientific

      • 14.16.1 Thermo Fisher Scientific Company Details

      • 14.16.2 Thermo Fisher Scientific Next Generation Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 Thermo Fisher Scientific Next Generation Cancer Diagnostics Product and Service

    • 14.17 Janssen Global Services

      • 14.17.1 Janssen Global Services Company Details

      • 14.17.2 Janssen Global Services Next Generation Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 Janssen Global Services Next Generation Cancer Diagnostics Product and Service

    • 14.18 Myriad Genetics

      • 14.18.1 Myriad Genetics Company Details

      • 14.18.2 Myriad Genetics Next Generation Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.18.3 Myriad Genetics Next Generation Cancer Diagnostics Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Next Generation Cancer Diagnostics

    • Figure Next Generation Cancer Diagnostics Picture

    • Table Global Next Generation Cancer Diagnostics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Next Generation Cancer Diagnostics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Next Generation Cancer Diagnostics Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Next Generation Cancer Diagnostics Consumption by Country (2017-2022)

    • Figure United States Next Generation Cancer Diagnostics Consumption and Growth Rate (2017-2022)

    • Table Europe Next Generation Cancer Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure China Next Generation Cancer Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Japan Next Generation Cancer Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure India Next Generation Cancer Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure South Korea Next Generation Cancer Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Global Next Generation Cancer Diagnostics Consumption Forecast by Country (2022-2028)

    • Figure United States Next Generation Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Next Generation Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Next Generation Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Next Generation Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Next Generation Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Next Generation Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Next Generation Sequencing Consumption and Growth Rate (2017-2022)

    • Figure Global qPCR & Multiplexing Consumption and Growth Rate (2017-2022)

    • Figure Global DNA Microarrays Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Next Generation Sequencing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global qPCR & Multiplexing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global DNA Microarrays Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Next Generation Cancer Diagnostics Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Next Generation Cancer Diagnostics Export by Region (Top 5 Countries) (2017-2028)

    • Table Sysmex Corporation (Foundation Year, Company Profile and etc.)

    • Table Sysmex Corporation Next Generation Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sysmex Corporation Next Generation Cancer Diagnostics Product and Service

    • Table Opko Health (Foundation Year, Company Profile and etc.)

    • Table Opko Health Next Generation Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Opko Health Next Generation Cancer Diagnostics Product and Service

    • Table Agilent Technologies (Foundation Year, Company Profile and etc.)

    • Table Agilent Technologies Next Generation Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Agilent Technologies Next Generation Cancer Diagnostics Product and Service

    • Table Abbott (Foundation Year, Company Profile and etc.)

    • Table Abbott Next Generation Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Next Generation Cancer Diagnostics Product and Service

    • Table Hologic (Foundation Year, Company Profile and etc.)

    • Table Hologic Next Generation Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hologic Next Generation Cancer Diagnostics Product and Service

    • Table Genomic Health (Foundation Year, Company Profile and etc.)

    • Table Genomic Health Next Generation Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Genomic Health Next Generation Cancer Diagnostics Product and Service

    • Table Almac Group (Foundation Year, Company Profile and etc.)

    • Table Almac Group Next Generation Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Almac Group Next Generation Cancer Diagnostics Product and Service

    • Table Cepheid (Foundation Year, Company Profile and etc.)

    • Table Cepheid Next Generation Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cepheid Next Generation Cancer Diagnostics Product and Service

    • Table Novartis AG (Foundation Year, Company Profile and etc.)

    • Table Novartis AG Next Generation Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis AG Next Generation Cancer Diagnostics Product and Service

    • Table PerkinElmer (Foundation Year, Company Profile and etc.)

    • Table PerkinElmer Next Generation Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table PerkinElmer Next Generation Cancer Diagnostics Product and Service

    • Table F Hoffmann-La Roche Ltd (Foundation Year, Company Profile and etc.)

    • Table F Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table F Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Product and Service

    • Table GE Healthcare (Foundation Year, Company Profile and etc.)

    • Table GE Healthcare Next Generation Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table GE Healthcare Next Generation Cancer Diagnostics Product and Service

    • Table Illumina (Foundation Year, Company Profile and etc.)

    • Table Illumina Next Generation Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Illumina Next Generation Cancer Diagnostics Product and Service

    • Table Qiagen (Foundation Year, Company Profile and etc.)

    • Table Qiagen Next Generation Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Qiagen Next Generation Cancer Diagnostics Product and Service

    • Table Koninklijke Philips NV (Foundation Year, Company Profile and etc.)

    • Table Koninklijke Philips NV Next Generation Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Koninklijke Philips NV Next Generation Cancer Diagnostics Product and Service

    • Table Thermo Fisher Scientific (Foundation Year, Company Profile and etc.)

    • Table Thermo Fisher Scientific Next Generation Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Thermo Fisher Scientific Next Generation Cancer Diagnostics Product and Service

    • Table Janssen Global Services (Foundation Year, Company Profile and etc.)

    • Table Janssen Global Services Next Generation Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Janssen Global Services Next Generation Cancer Diagnostics Product and Service

    • Table Myriad Genetics (Foundation Year, Company Profile and etc.)

    • Table Myriad Genetics Next Generation Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Myriad Genetics Next Generation Cancer Diagnostics Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US